Supplemental material
Journal of Medical Economics
Volume 25, 2022 - Issue 1
Cardiovascular
Cost-effectiveness of a paclitaxel-eluting stent (Eluvia) compared to Zilver PTX for endovascular femoropopliteal intervention
William A. Graya Division of Cardiovascular Diseases, Lankenau Heart Institute, Philadelphia, PA, USACorrespondence[email protected]
https://orcid.org/0000-0003-4676-2839
https://orcid.org/0000-0003-4676-2839, , , , Alysha M. McGovernb Boston Scientific, Marlborough, MA, USAhttps://orcid.org/0000-0002-6486-1788
https://orcid.org/0000-0002-6486-1788, Michael R. Jaffb Boston Scientific, Marlborough, MA, USAhttps://orcid.org/0000-0002-3772-5887
https://orcid.org/0000-0002-3772-5887, & Stefan Müller-Hülsbecke Diaconess Hospital Flensburg, Flensburg, Germanyhttps://orcid.org/0000-0001-6011-9466
https://orcid.org/0000-0001-6011-9466 show all